Tonix Pharmaceuticals announced that its management will present and hold one-on-one meetings at the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on November 10, 2026. The presentation will be led by CEO Seth Lederman and will cover Tonix's commercial-stage biopharmaceutical developments, including their flagship fibromyalgia drug TONMYA and other CNS, infectious disease, and immunology programs. A live webcast will be available on Tonix's investor website. This event highlights Tonix's ongoing efforts to advance treatments for central nervous system disorders, infectious diseases, and immunology conditions with unmet medical needs.
Tonix Pharmaceuticals is the subject of this update. For readers following the health sector, here is Pluang's market snapshot as of Nov 04, 2026 18:41 WIB: Out of 150 priced health-sector US stocks, 118 rose and 24 fell. Notable movers include HCA Health Inc at USD 485.73 with a 4.94% increase and a typical hold time of 77 days, Tenet Healthcare Corporation at USD 279.75 up 4.90% with 100% sell order activity and a 17-day hold time, and Centene Corp at USD 70.40 with a 4.33% rise and a 43-day hold time.
KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...
JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...
Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc as of November 3, 2026. This disclosure is part of regulatory requirements under the Takeover Code for investors holding 1% or more in relevan...
Dimensional Fund Advisors Ltd. has disclosed an interest in 1,516,595 ordinary shares of DCC Energy plc, representing 1.78% of the company's shares as of November 3, 2026. The disclosure follows regulatory requirements under the Irish Takeover Panel ...
Wayfair reported Q3 2026 net revenue of $3.4 billion, up 9.7% year-over-year, driven by an 11.4% increase in U.S. revenue. Active customers grew 4.7% to 22.2 million, with orders up 12.2%, signaling strong market share gains. The company posted a net...
